Heart Other Current Liab from 2010 to 2024

HSCS Stock  USD 2.67  0.05  1.91%   
Heart Test Other Current Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Current Liabilities will likely drop to about 627.4 K in 2024. From the period from 2010 to 2024, Heart Test Other Current Liabilities quarterly data regression had r-value of  0.77 and coefficient of variation of  154.79. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
701.3 K
Current Value
627.4 K
Quarterly Volatility
360.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
  
Check out the analysis of Heart Test Correlation against competitors.

Latest Heart Test's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Heart Test Laboratories over the last few years. It is Heart Test's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Heart Other Current Liab Regression Statistics

Arithmetic Mean232,673
Geometric Mean9,974
Coefficient Of Variation154.79
Mean Deviation308,604
Median1,220
Standard Deviation360,166
Sample Variance129.7B
Range1.1M
R-Value0.77
Mean Square Error56.4B
R-Squared0.60
Significance0.0007
Slope62,198
Total Sum of Squares1.8T

Heart Other Current Liab History

2024627.4 K
2023701.3 K
2022672 K
20211.1 M
2020422.4 K

About Heart Test Financial Statements

Heart Test shareholders use historical fundamental indicators, such as Other Current Liab, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Liabilities701.3 K627.4 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.